ALTE03N1: Key Adverse Events Following Childhood Cancer
[Protocol 05-070] |
Sklar, Charles |
|
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib
[Protocol 11-030] |
Shukla, Neerav |
- Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myelocytic Leukemia
|
Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia
[Protocol 11-002] |
Shukla, Neerav |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase II Study of Concurrent Intensity-Modulated Radiation Therapy (IMRT),
Paclitaxel, and Pazopanib/Placebo for the Treatment of Anaplastic Thyroid Cancer
[Protocol 10-186] |
Sherman, Eric |
|
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046] |
Seidman, Andrew |
- Brain Tumors, Metastatic
- Breast Cancer
|
A Phase I Study of BMS-663513 (Anti-CD137 Antibody) in Patients with Advanced or Metastatic Solid Tumors
[Protocol 11-212] |
Segal, Neil |
|
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma
[Protocol 11-085] |
Segal, Neil |
|
A Phase I Study of MED14736 in Patients with Advanced Solid Tumors
[Protocol 12-179] |
Segal, Neil |
|
A Phase I Study of BMS-986015 plus BMS-936558 in Patients with Advanced Solid Tumors
[Protocol 12-224] |
Segal, Neil |
- Colorectal Cancer
- Kidney Cancer
- Lung Cancer, Non-Small Cell
- Melanoma
- Ovarian Cancer
|
A Phase I Study of IMMU-130 in Patients with Colorectal Cancer
[Protocol 11-074] |
Segal, Neil |
|
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167] |
Schwartz, Gary |
|
A Phase III Study of Cabozantinib (XL184) versus Mitoxantrone/Prednisone in Men with Previously Treated Symptomatic Castration-Resistant Prostate Cancer
[Protocol 12-032] |
Scher, Howard |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Quality of Life
|
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187] |
Scher, Howard |
- Prostate Cancer
- Rising PSA After Primary Therapy
|
A Study of Allogeneic Stem Cell Transplantation in HIV-Infected Patients with Hematologic Cancers
[Protocol 12-092] |
Sauter, Craig |
- Blood and Marrow Transplantation
- Hematology
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I Study of High-Dose Therapy and Autologous Stem Cell Transplantation Followed by Modified T Cells for Aggressive B-Cell Non-Hodgkin Lymphoma
[Protocol 12-117] |
Sauter, Craig |
|
Quality of Life Outcomes Following Minimally Invasive versus Open Esophagectomy for Esophageal Cancer
[Protocol 12-003] |
Sarkaria, Inderpal |
|
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
[Protocol 12-087] |
Saltz, Leonard |
|
A Phase I Trial of a New Vaccine (Globo-H-GM2-sTn-TF-Tn) for Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
[Protocol 09-184] |
Sabbatini, Paul |
|
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169] |
Rusch, Valerie |
- Breast Cancer
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
- Mesothelioma
|
A Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116] |
Roth, Andrew |
- Breast Cancer
- Geriatrics
- Prostate Cancer
- Localized Disease
- Quality of Life
|
